quinoxalines has been researched along with transforming growth factor beta in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 5 (20.83) | 29.6817 |
| 2010's | 14 (58.33) | 24.3611 |
| 2020's | 4 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gerken, U; Hossmann, K; Vogel, P; Wiessner, C; Yamashita, K | 1 |
| Gandhi, CR; Uemura, T | 1 |
| Darley-Usmar, V; Murphy-Ullrich, JE; Poczatek, MH; Shiva, S; Wang, S | 1 |
| Diab-Assaf, M; Gali-Muhtasib, HU; Haddadin, MJ | 1 |
| Burgert, M; Cadacio, C; Everitt, JI; Frazier, KS; Gold, LI; Laping, NJ; Portis, MJ; Walker, CL | 1 |
| Dunkern, TR; Feurstein, D; Hatzelmann, A; Rossi, GA; Sabatini, F | 1 |
| Asencio, C; Génot, E; Le Roux-Goglin, E; Mégraud, F; Spuul, P; Varon, C | 1 |
| Aaron, KJ; Sanders, PW; Ying, WZ | 1 |
| Baker, AH; Denby, L; McBride, M; Ramdas, V | 1 |
| Aurora, AB; Baker, AH; Conway, BR; Delles, C; Denby, L; Dickinson, B; Grant, JS; Kipgen, D; Lu, R; McClure, JD; Ramdas, V; van Rooij, E | 1 |
| Kim, DK; Min, KN; Nam, JS; Park, CY; Park, SY; Sheen, YY; Son, JY | 1 |
| Imada, K; Inokuchi, J; Itsumi, M; Kuruma, H; Naito, S; Oda, Y; Shiota, M; Takeuchi, A; Tatsugami, K; Uchiumi, T; Yokomizo, A | 1 |
| Abrigo, J; Cabello-Verrugio, C; Cabrera, D; Di Capua, G; Morales, MG; Simon, F | 1 |
| Chen, X; Fang, H; Hou, J; Wu, X; Xu, F; Yin, S; Zhang, J; Zhang, X | 1 |
| Aimaiti, Y; Feng, Y; Jin, X; Li, D; Mao, X; Wang, W | 1 |
| Harasymczuk, J; Jagodziński, PP; Jakub, G; Lehmann, TP | 1 |
| Bajaj, A; Decker-Rockefeller, B; Li, QF; Pumiglia, K | 1 |
| Cheng, G; Cui, L; Dai, M; Hao, H; Huang, D; Huang, L; Li, D; Liu, Z; Lu, Q; Peng, D; Wang, X; Wang, Y; Xing, D; Yuan, Z | 1 |
| Brandan, E; Contreras, O; Faundez-Contreras, J; González, D; Lipson, KE; Murphy-Ullrich, JE; Rebolledo, DL; Vio, CP | 1 |
| Avan, A; Binabaj, MM; Ferns, GA; Hassanian, SM; Khazaei, M; Khoshakhlagh, M; Soleimani, A | 1 |
| He, J; Leng, Z; Li, M; Qian, M; Wen, H; Yu, Q | 1 |
| Aoyama, T; Sakai, M; Sumiyoshi, T; Urayama, K; Yoshimura, R | 1 |
| Sakai, M; Yoshimura, R | 1 |
| Basta, MD; Paulson, H; Walker, JL | 1 |
2 review(s) available for quinoxalines and transforming growth factor beta
| Article | Year |
|---|---|
The effect of Echinococcus granulosus on spleen cells and TGF-β expression in the peripheral blood of BALB/c mice.
Topics: Animals; Echinococcosis; Echinococcus granulosus; Female; Imidazoles; Killer Cells, Natural; Mice; Mice, Inbred BALB C; Protein Serine-Threonine Kinases; Quinoxalines; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Spleen; T-Lymphocytes; Transforming Growth Factor beta | 2017 |
Therapeutic potential of pharmacological TGF-β signaling pathway inhibitors in the pathogenesis of breast cancer.
Topics: Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Imidazoles; Quinoxalines; Receptors, Transforming Growth Factor beta; Signal Transduction; Transforming Growth Factor beta | 2019 |
22 other study(ies) available for quinoxalines and transforming growth factor beta
| Article | Year |
|---|---|
Biphasic expression of TGF-beta1 mRNA in the rat brain following permanent occlusion of the middle cerebral artery.
Topics: Animals; Arterial Occlusive Diseases; Brain; Cerebral Arteries; Chronic Disease; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Male; Quinoxalines; Rats; Rats, Inbred F344; RNA, Messenger; Transforming Growth Factor beta | 1999 |
Inhibition of DNA synthesis in cultured hepatocytes by endotoxin-conditioned medium of activated stellate cells is transforming growth factor-beta and nitric oxide-independent.
Topics: Animals; Antibodies, Monoclonal; Cells, Cultured; Culture Media, Conditioned; DNA; Dose-Response Relationship, Drug; Endotoxins; Gene Expression Regulation, Enzymologic; Hepatocytes; Interleukin-1; Interleukin-6; Lipopolysaccharides; Liver; Male; Neutralization Tests; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Oxadiazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor alpha; Transforming Growth Factor beta | 2001 |
Nitric oxide and cGMP-dependent protein kinase regulation of glucose-mediated thrombospondin 1-dependent transforming growth factor-beta activation in mesangial cells.
Topics: Animals; Cell Line; Cells, Cultured; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; Glomerular Mesangium; Glucose; Humans; Immunoblotting; Mink; Models, Biological; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Oxadiazoles; Plasminogen Activator Inhibitor 1; Promoter Regions, Genetic; Quinoxalines; Rats; RNA, Messenger; Signal Transduction; Thionucleotides; Thrombospondin 1; Time Factors; Transfection; Transforming Growth Factor beta | 2002 |
Quinoxaline 1,4-dioxides induce G2/M cell cycle arrest and apoptosis in human colon cancer cells.
Topics: Apoptosis; bcl-2-Associated X Protein; Cell Cycle; Cell Division; Cells, Cultured; Colonic Neoplasms; Cyclin B; Extracellular Signal-Regulated MAP Kinases; Humans; Proto-Oncogene Proteins c-bcl-2; Quinoxalines; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
Tumor-specific efficacy of transforming growth factor-beta RI inhibition in Eker rats.
Topics: Activin Receptors, Type I; Animals; Apoptosis; Carcinoma, Renal Cell; Female; Imidazoles; Kidney Neoplasms; Leiomyoma; Mitosis; Protein Serine-Threonine Kinases; Quinoxalines; Rats; Rats, Inbred Strains; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Signal Transduction; Transforming Growth Factor beta; Uterine Neoplasms | 2007 |
Inhibition of TGF-beta induced lung fibroblast to myofibroblast conversion by phosphodiesterase inhibiting drugs and activators of soluble guanylyl cyclase.
Topics: Actins; Benzamides; Benzoates; Blotting, Western; Cell Differentiation; Cells, Cultured; Cyclic GMP; Dinoprostone; Drug Synergism; Enzyme Activators; Fibroblasts; Fibrosis; Guanylate Cyclase; Humans; Immunohistochemistry; Isoenzymes; Lung; Myocytes, Smooth Muscle; Natriuretic Peptide, Brain; Nitric Oxide Donors; Nitroso Compounds; Oxadiazoles; Phosphodiesterase Inhibitors; Piperazines; Purines; Pyridines; Quinoxalines; Receptors, Cytoplasmic and Nuclear; Sildenafil Citrate; Soluble Guanylyl Cyclase; Sulfones; Transforming Growth Factor beta | 2007 |
Helicobacter infection induces podosome assembly in primary hepatocytes in vitro.
Topics: Actin Cytoskeleton; Animals; Benzamides; Cell Line, Tumor; Dioxoles; Helicobacter Infections; Helicobacter pylori; Hepatocytes; Humans; Imidazoles; Liver; Mice; Primary Cell Culture; Quinoxalines; Transforming Growth Factor beta | 2012 |
Transforming growth factor-β regulates endothelial function during high salt intake in rats.
Topics: Animals; Aorta; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Myocytes, Smooth Muscle; Nitric Oxide Synthase Type III; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Quinoxalines; Rats; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Smad2 Protein; Sodium Chloride, Dietary; Transforming Growth Factor beta | 2013 |
Canonical transforming growth factor-β signaling regulates disintegrin metalloprotease expression in experimental renal fibrosis via miR-29.
Topics: Animals; Cell Line; Disintegrins; Fibrosis; Gene Expression Regulation, Enzymologic; Glomerulonephritis; Imidazoles; Male; Mice; MicroRNAs; Quinoxalines; Rats; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta | 2013 |
MicroRNA-214 antagonism protects against renal fibrosis.
Topics: Animals; Disease Models, Animal; Fibrosis; Gene Deletion; Gene Expression; Humans; Imidazoles; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Quinoxalines; Renal Insufficiency, Chronic; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta; Ureteral Obstruction | 2014 |
An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Nucleus; Drug Screening Assays, Antitumor; Epithelial-Mesenchymal Transition; Female; Humans; Imidazoles; Lung; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Neoplasm Transplantation; Protein Serine-Threonine Kinases; Protein Transport; Quinoxalines; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Transforming Growth Factor beta; Tumor Burden | 2014 |
Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
Topics: Adenocarcinoma; Androgens; Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Combined Modality Therapy; Epithelial-Mesenchymal Transition; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Male; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Nuclear Proteins; Orchiectomy; Prostatic Neoplasms; Quinoxalines; Random Allocation; Receptors, Androgen; RNA Interference; RNA, Small Interfering; Signal Transduction; Transforming Growth Factor beta; Twist-Related Protein 1; Xenograft Model Antitumor Assays | 2015 |
Apocynin inhibits the upregulation of TGF-β1 expression and ROS production induced by TGF-β in skeletal muscle cells.
Topics: Acetophenones; Animals; Benzophenanthridines; Cell Line; Imidazoles; Mice; Muscle Fibers, Skeletal; Protein Kinase C; Quinoxalines; Reactive Oxygen Species; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation | 2015 |
TGFβ signaling controls intrahepatic bile duct development may through regulating the Jagged1-Notch-Sox9 signaling axis.
Topics: Actins; Animals; Bile Ducts, Intrahepatic; Cells, Cultured; Epithelial Cells; Hepatocytes; Imidazoles; Jagged-1 Protein; Mesoderm; Mice; Myofibroblasts; Quinoxalines; Receptors, Notch; Signal Transduction; SOX9 Transcription Factor; Transforming Growth Factor beta | 2018 |
Transforming growth factor β mediates communication of co-cultured human nucleus pulposus cells and mesenchymal stem cells.
Topics: Adolescent; Benzamides; Cells, Cultured; Coculture Techniques; Collagen Type I; Collagen Type I, alpha 1 Chain; Dioxoles; Humans; Imidazoles; Mesenchymal Stem Cells; MicroRNAs; Nucleus Pulposus; Paracrine Communication; Quinoxalines; Receptor, Transforming Growth Factor-beta Type I; SOX9 Transcription Factor; Transforming Growth Factor beta | 2018 |
Activation of Ras in the Vascular Endothelium Induces Brain Vascular Malformations and Hemorrhagic Stroke.
Topics: Activin Receptors, Type II; Animals; Brain; Cells, Cultured; Endothelial Cells; Female; Fluorescent Antibody Technique; Imidazoles; Immunohistochemistry; Male; Mice; Mice, Transgenic; Pericytes; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); Quinoxalines; Receptor, Transforming Growth Factor-beta Type I; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta; Vascular Malformations | 2018 |
Signaling pathways involved in the expression of SZNF and the target genes binding with SZNF related to cyadox.
Topics: Animals; Extracellular Signal-Regulated MAP Kinases; Hepatocytes; Janus Kinase 2; JNK Mitogen-Activated Protein Kinases; NF-kappa B; Oncogene Protein v-akt; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphorylation; Quinoxalines; RNA Recognition Motif Proteins; RNA, Messenger; Signal Transduction; Smad Proteins; STAT Transcription Factors; Swine; Transforming Growth Factor beta; Zinc Fingers | 2018 |
Denervation-induced skeletal muscle fibrosis is mediated by CTGF/CCN2 independently of TGF-β.
Topics: Animals; Antibodies, Monoclonal, Humanized; Benzamides; Connective Tissue Growth Factor; Dioxoles; Extracellular Matrix; Fibrosis; Gene Expression Regulation; Imidazoles; Male; Mice; Models, Animal; Muscle Denervation; Muscle, Skeletal; Quinoxalines; Signal Transduction; Transforming Growth Factor beta | 2019 |
Inhibiting of self-renewal, migration and invasion of ovarian cancer stem cells by blocking TGF-β pathway.
Topics: Cadherins; Cell Line, Tumor; Cell Movement; Cell Self Renewal; Epithelial-Mesenchymal Transition; Female; Humans; Imidazoles; Neoplasm Invasiveness; Neoplastic Stem Cells; Ovarian Neoplasms; Phosphorylation; Quinoxalines; RNA, Messenger; Signal Transduction; Smad Proteins; Transforming Growth Factor beta; Vimentin | 2020 |
GPR91 antagonist and TGF-β inhibitor suppressed collagen production of high glucose and succinate induced HSC activation.
Topics: Animals; Cells, Cultured; Collagen; Glucose; Hepatic Stellate Cells; Imidazoles; Liver Cirrhosis; Male; Quinoxalines; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Succinic Acid; Transforming Growth Factor beta | 2020 |
Mechanotransduction-Targeting Drugs Attenuate Stiffness-Induced Hepatic Stellate Cell Activation in Vitro.
Topics: Actins; Adenosine Triphosphate; Animals; Benzamides; Cells, Cultured; Colchicine; Collagen Type I; Hepatic Stellate Cells; Imidazoles; Integrins; Male; Mechanotransduction, Cellular; Paclitaxel; Piperazines; Pyrazines; Quinoxalines; Rats, Sprague-Dawley; Roscovitine; Sulfonamides; Transforming Growth Factor beta; Tubulin Modulators | 2021 |
The local wound environment is a key determinant of the outcome of TGFβ signaling on the fibrotic response of CD44
Topics: Actins; Animals; Blotting, Western; Capsule Opacification; Cataract Extraction; Cell Proliferation; Chick Embryo; Collagen Type I; Disease Models, Animal; Fibronectins; Fibrosis; Hyaluronan Receptors; Imidazoles; Integrin alphaVbeta3; Microscopy, Fluorescence; Myofibroblasts; Posterior Capsule of the Lens; Postoperative Complications; Pyrazoles; Pyrroles; Quinoxalines; Receptor, Transforming Growth Factor-beta Type I; Signal Transduction; Transforming Growth Factor beta; Wound Healing | 2021 |